TG Therapeutics Inc (TGTX)

11.05
0.90 7.53
NASDAQ : Health Care
Prev Close 11.95
Open 12.45
Day Low/High 11.00 / 12.69
52 Wk Low/High 5.61 / 18.60
Volume 2.43M
Avg Volume 2.32M
Exchange NASDAQ
Shares Outstanding 63.63M
Market Cap 773.09M
EPS -1.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Don't Be Surprised If Dip Buyers Jump In on Any Pullback

Don't Be Surprised If Dip Buyers Jump In on Any Pullback

We'll see what happens in the way of reaction to Trump's tax policy this afternoon, but if we sell off I'm likely going to be a buyer.

Desire to Add Exposure Leads Indices Higher

Desire to Add Exposure Leads Indices Higher

The fact that many traders weren't well-positioned for Monday's move up is helping to create one-way action this morning.

If You Don't Buy These 5 Stocks Before Their Looming Breakout, It's Your Loss

If You Don't Buy These 5 Stocks Before Their Looming Breakout, It's Your Loss

Here's how to potentially rake in some fat profits off a number of hot breakout setups.

TG Therapeutics, Inc. Announces Clinical Data Presentations At The Upcoming 53rd Annual Meeting Of The American Society Of Clinical Oncology

TG Therapeutics, Inc. Announces Clinical Data Presentations At The Upcoming 53rd Annual Meeting Of The American Society Of Clinical Oncology

Positive results from the GENUINE Phase 3 study to be featured in an oral presentation

TG Therapeutics Stock Sees Short Interest Increase 21%

TG Therapeutics Stock Sees Short Interest Increase 21%

The most recent short interest data has been released for the 03/31/2017 settlement date, which shows a 1,802,705 share increase in total short interest for TG Therapeutics Inc , to 10,443,471, an increase of 20.86% since 03/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Twilio, HubSpot, TG Therapeutics, Under Armour: 'Mad Money' Lightning Round

Twilio, HubSpot, TG Therapeutics, Under Armour: 'Mad Money' Lightning Round

Jim Cramer is bullish on Twilio, HubSpot and Cemex; he's bearish on Suburban Propane Partners.

Don't Be Fooled by This Retail Relief Rally: Cramer's 'Mad Money' Recap (Thursday 4/6/17)

Don't Be Fooled by This Retail Relief Rally: Cramer's 'Mad Money' Recap (Thursday 4/6/17)

No, people aren't suddenly deciding they want to go back to shopping at the mall, says Jim Cramer.

Commit To Buy TG Therapeutics At $10, Earn 29.1% Annualized Using Options

Commit To Buy TG Therapeutics At $10, Earn 29.1% Annualized Using Options

Investors eyeing a purchase of TG Therapeutics Inc shares, but cautious about paying the going market price of $11.43/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $10 strike, which has a bid at the time of this writing of $1.15.

TG Therapeutics, Inc. To Present At The 27th Annual Oppenheimer Healthcare Conference

TG Therapeutics, Inc. To Present At The 27th Annual Oppenheimer Healthcare Conference

Presentation Scheduled for Tuesday, March 21, 2017 at 3:20pm ET

TG Therapeutics, Inc. To Present At The 29th Annual ROTH Conference

TG Therapeutics, Inc. To Present At The 29th Annual ROTH Conference

Presentation Scheduled for Tuesday, March 14, 2017 at 3:00pm PT

Biotech Stock Mailbag: Puma's Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps

Biotech Stock Mailbag: Puma's Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps

TheStreet's Adam Feuerstein answers reader questions about biotech stocks.

TG Therapeutics, Inc. To Host Conference Call On Fourth Quarter And Year-End 2016 Financial Results And Business Update

TG Therapeutics, Inc. To Host Conference Call On Fourth Quarter And Year-End 2016 Financial Results And Business Update

Investor Conference Call to be held Friday, March 10, 2017 at 8:30am ET

The 'Gnarly 9' Biotechs Will Test the FDA's Mettle

The 'Gnarly 9' Biotechs Will Test the FDA's Mettle

The firms all have drugs they want the feds to bend the rules to approve.

Could These 9 Drugs Gain FDA Approval in the Age of Trump?

Could These 9 Drugs Gain FDA Approval in the Age of Trump?

Nine biotech and drug companies want FDA approval, but need changed standards to get it.

The 'Gnarly 9' Biotechs Will Test the FDA's Mettle

The 'Gnarly 9' Biotechs Will Test the FDA's Mettle

The firms all have drugs they want the feds to bend the rules to approve.

Treehouse Foods, Arconic, Kinder Morgan, Chesapeake Energy: 'Mad Money' Lightning Round

Treehouse Foods, Arconic, Kinder Morgan, Chesapeake Energy: 'Mad Money' Lightning Round

Jim Cramer is bullish on Arconic, Treehouse Foods, Magellan Midstream Partners.

Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Jim Cramer says if Trump really wants to lower drug prices, he should target our trading partners.

How to Trade Monday's Most Active Stocks - Snap, GM, TG Therapeutics and More

How to Trade Monday's Most Active Stocks - Snap, GM, TG Therapeutics and More

These stocks are showing short-term gain catalysts and longer-term growth potential. Here's how to trade them.

Notable Monday Option Activity: TGTX, OMED, KMB

Notable Monday Option Activity: TGTX, OMED, KMB

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in TG Therapeutics Inc , where a total volume of 3,146 contracts has been traded thus far today, a contract volume which is representative of approximately 314,600 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 78.1% of TGTX's average daily trading volume over the past month, of 403,030 shares.